Welcure Drugs & Pharmaceuticals Limited

Equities

WELCURE6

INE331C01017

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:58 2024-07-12 am EDT			5-day change	1st Jan Change
6.66 ^INR	+0.15%		+10.26%	+72.99%

Jun. 10	Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Branch Office of the Company	CI
Jun. 10	Welcure Drugs & Pharmaceuticals Limited announced that it expects to receive INR 247.5 million in funding	CI

Welcure Drugs & Pharmaceuticals Ltd Appoints Shri Nitin Singhal as Chairman of the Board

January 14, 2019 at 01:35 am EST

The Board of Directors of Welcure Drugs & Pharmaceuticals Ltd. in their meeting held on January 12, 2019 has appointed Shri Nitin Singhal, Non Executive Director, as Chairman of the board.

Latest news about Welcure Drugs & Pharmaceuticals Limited

Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Branch Office of the Company	Jun. 10	CI
Welcure Drugs & Pharmaceuticals Limited announced that it expects to receive INR 247.5 million in funding	Jun. 09	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	Jun. 04	CI
Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024	Mar. 22	CI
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO	Feb. 15	MT
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer	Feb. 15	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office	Feb. 14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes	Nov. 14	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director	23-10-30	CI
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes	23-09-30	CI
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi	23-09-04	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-07-11	CI
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Director Resignations, with Effect from October 8, 2022	22-10-08	CI
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Sudhir Chandra as Managing Director, with Effect from October 8, 2022	22-10-08	CI

Chart Welcure Drugs & Pharmaceuticals Limited

Duration

Period

Chart Welcure Drugs & Pharmaceuticals Limited

More charts

Company Profile

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in providing services for procurements of order.

Sector

Pharmaceuticals

Calendar

2024-10-20 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
WELCURE DRUGS & PHARMACEUTICALS LIMITED	+72.99%	1.08M
MCKESSON CORPORATION	+25.72%	75.74B
CARDINAL HEALTH, INC.	-4.79%	23.24B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+17.81%	8.76B
HUADONG MEDICINE CO., LTD	-31.67%	6.69B
H. LUNDBECK A/S	+20.57%	5.58B
GALENICA AG	+4.12%	4.22B
EBOS GROUP LIMITED	-3.94%	3.99B
MEDIPAL HOLDINGS CORPORATION	+14.24%	3.39B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+10.59%	3.23B

Pharmaceuticals Wholesale